Study Sees Survival Boost For BRCA1/2 Carriers Tested Before Breast Cancer Diagnosis

NEW YORK – Women carrying pathogenic germline BRCA1/2 variants who develop breast cancer appear to fare better if their germline risk variants were uncovered prior to their cancer diagnosis, even if they do not undergo preventative procedures such as risk-reduction surgery, according to new research from Israel.